These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4987126)

  • 61. Vaccination with RA 27-3 rubella vaccine.
    Buser F; Nicolas A; L'Etoile M
    Am J Dis Child; 1971 Jul; 122(1):53-6. PubMed ID: 5567406
    [No Abstract]   [Full Text] [Related]  

  • 62. Vaccination with combined live measles and rubella vaccines.
    Ramos Alvarez M; Bessudo L
    Rev Invest Salud Publica; 1972; 32(2):110-5. PubMed ID: 4584450
    [No Abstract]   [Full Text] [Related]  

  • 63. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
    Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S
    Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

  • 66. Immunization with live attenuated rubella virus vaccine (HPV-77). Clinical and serological results in children and adolescents in Israel.
    Goldblum N; Swartz TA; Klingberg W; Goldwasser RA; Klingberg MA
    Am J Dis Child; 1969 Aug; 118(2):190-6. PubMed ID: 5815861
    [No Abstract]   [Full Text] [Related]  

  • 67. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A controlled family study of live, attenuated rubella-virus vaccine.
    Lefkowitz LB; Rafajko RR; Federspiel CF; Quinn RW
    N Engl J Med; 1970 Jul; 283(5):229-32. PubMed ID: 4912790
    [No Abstract]   [Full Text] [Related]  

  • 69. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I; Peltola H; Leinikki P; Valle M
    Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Results of a trial of anti-rubella vaccination with vaccine made up of the "Cendehill-51" live and attenuated virus strain].
    Portolani M; Rondinini B; Brighi W; Maccolini E
    Minerva Med; 1970 Apr; 61(30 Suppl):1590-4. PubMed ID: 5439724
    [No Abstract]   [Full Text] [Related]  

  • 72. [Trials of vaccination against rubella with the Cendehill C-51 strain of live and attenuated virus].
    Fara GM; Galli MG; Nodari R; Saccani CF; Marangoni L; Bozzetti A; Tarantino F
    Minerva Med; 1970 Apr; 61(30 Suppl):1574-7. PubMed ID: 5439721
    [No Abstract]   [Full Text] [Related]  

  • 73. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
    Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Live attenuated rubella virus vaccine given in an orphanage just prior to a rubella epidemic.
    Detels R; Kim KS; Gutman L; Grayston JT
    JAMA; 1969 Jan; 207(4):709-12. PubMed ID: 5818187
    [No Abstract]   [Full Text] [Related]  

  • 75. Studies on live rubella vaccine. I. Propagation of rubella virus in developing chick embryos and its laboratory characterization.
    Okuno Y; Minekawa Y; Suzuki N; Takahashi M
    Biken J; 1968 Dec; 11(4):235-42. PubMed ID: 4976546
    [No Abstract]   [Full Text] [Related]  

  • 76. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 77. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M; Berger R; Glück R; Wegmann A
    Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Immunization of healthy children with mumps-rubella bivalent live vaccine and simultaneous vaccination with mumps-rubella and varicella vaccines].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1271-5. PubMed ID: 1791323
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine.
    Schmidt NJ; Lennette EH
    Am J Epidemiol; 1970 Apr; 91(4):351-4. PubMed ID: 4912184
    [No Abstract]   [Full Text] [Related]  

  • 80. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.